Skip to main content
Equibles
WLY logo

WLY · John Wiley & Sons, Inc.

Track WLY — free

Use WLY with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$48.19 -2.47 (-4.88%) At close · Sep 4
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.44B
Shares
50.68M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$48.19 Open$49.50 Day$46.51–51.15 52W close$28.79–55.72 Avg vol 30d482K Short int4.5M · 8.9% float · 11.2d Short vol72% Last earningsSep 3, 2026 DataJan 2020–Sep 2026 Filing10-Q · Sep 4

Up next

Next earnings call
Dec 3, 2026 Est · unconfirmed · in 12 wks
Latest filing: 10-Q
filed Sep 4, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$1.67B
Trailing 12 months
Net income (TTM)
$198.19M
Trailing 12 months
Revenue growth YoY
-2.6%
Year over year
Operating margin
14.9%
Trailing 12 months
P / E (TTM)
13.0
Trailing earnings · reciprocal yield 7.7%
FCF yield
9.3%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$1.18B
Latest balance sheet
Dividend yield
3.0%
Trailing 12 months
Shares change YoY
-6.0%
Year over year · fewer shares
Price change (1Y)
+26.0%
Trailing year
Short interest
8.9%
Latest settlement · 11.2 days to cover
View all 114 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Strong Sentiment Neutral Fundamentals Excellent Quant / Vol High
Market backdrop VIX 14.5 · calm Equity put/call 0.58
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +20%
above
Price vs 50-day avg −6%
below
RSI (14) 36
neutral
MACD trend Negative
52-week position 72%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Strong
1-month return −8%
trailing
6-month return +31%
trailing
YTD return +57%
this year
Relative strength +16%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $51 › 200d $40 — 50d above 200d
Institutional flow Accumulating
+7% holders QoQ · +54 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
8.92% of float · ▲ +8.6% MoM · 11.2 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr high
267 holders — near 3-yr high, broad support
Squeeze score 81
high risk · 0–100
Fundamentals
Excellent
Revenue growth +5%
Y/Y
Gross margin 73%
expanding
EPS growth +172%
Y/Y
Free cash flow $209.4M
Valuation P/E 13
below peers
Buyback $192.4M
remaining
Balance sheet $607.8M
net debt
Quant / Vol
risk profile
High
Volatility 37%
annualized · 1-yr
Max drawdown −32%
past year
ATR 4.8%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Sep 3, 2026
Adjusted EBITDA margin · fiscal 27 Non-GAAP Initiated 26.5% – 27.5%
Adjusted EPS · fiscal 27 Non-GAAP Initiated $4.60 – $5.05
Prior guidance period ended · from the Earnings Call filed Oct 31, 2021
Revenue · fiscal '22 $2.07B – $2.1B
Adjusted EBITDA · fiscal '22 $415M – $435M
Adjusted EPS · fiscal '22 $4.00 – $4.25
Cash earnings · fiscal '22 $200M – $220M
Guided vs delivered · last 1 settled
Revenue fiscal '22
guided $2.07B – $2.1B
$2.08B In line

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
2 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+20% Bullish
Price vs 50-day avg
−6% Bearish
RSI (14)
36 Neutral
MACD trend
Negative Bearish
52-week position
72% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $51 › 200d $40 — 50d above 200d
Institutional flow Accumulating
+7% holders QoQ · +54 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
8.92% of float · ▲ +8.6% MoM · 11.2 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr high
267 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $29 Now $48 · 72% Range high $56
vs 200-day avg +20% vs 50-day avg -6%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted EPS non-GAAP $0.44 the first quarter of fiscal year 2027 —
Adjusted Operating Income non-GAAP $31M the first quarter of fiscal year 2027 —
AI licensing revenue $14M the first quarter of fiscal year 2027 —
AI model training customers 23 Q1 2027 —
Capex $14M Q1 2027 —
Corporate Expenses non-GAAP $33M Q1 2027 —
CY26 journal renewal retention 99% CY26 —
Emerald acquisition consideration $450M the first quarter of fiscal year 2027 —
Free Cash Flow non-GAAP $70M the first quarter of fiscal year 2027 —
Free cash flow less product development spending non-GAAP -$69.65M Three Months Ended July 31, 2026 —
GAAP → non-GAAP reconciliation
GAAP Net cash used in operating activities -$55.27M
-$11.2M Less: Additions to technology, property, and equipment
-$3.18M Less: Product development spending
= Free cash flow less product development spending -$69.65M
Journals on new publishing platform 1,600 Q1 2027 —
Learning Adjusted EBITDA non-GAAP $14M the first quarter of fiscal year 2027 —
Learning Adjusted EBITDA Margin non-GAAP 15.1% Q1 2027 —
Nexus publisher partners 71 Q1 2027 —
Non-GAAP Adjusted EBITDA non-GAAP $67.82M Three Months Ended July 31, 2026 —
Non-GAAP Adjusted Effective Tax Rate non-GAAP 24.6% Three Months Ended July 31, 2026 —
Non-GAAP Adjusted Income Before Taxes non-GAAP $30.35M Three Months Ended July 31, 2026 —
GAAP → non-GAAP reconciliation
GAAP US GAAP (Loss) Income Before Taxes -$12.58M
+$11.04M Acquisition and integration related costs
+$16.53M Restructuring and related charges
+$16K Foreign exchange losses (gains) on intercompany transactions
+$16.46M Amortization of acquired intangible assets
-$1.11M Net (gain) loss on sale of businesses and assets
= Non-GAAP Adjusted Income Before Taxes $30.35M
Non-GAAP Adjusted Income Tax Provision non-GAAP $7.48M Three Months Ended July 31, 2026 —
GAAP → non-GAAP reconciliation
GAAP US GAAP Income Tax (Benefit) Provision -$850K
+$936K Income Tax Impact of Adjustments: Acquisition and integration related costs
+$3.31M Income Tax Impact of Adjustments: Restructuring and related charges
+$10K Income Tax Impact of Adjustments: Foreign exchange losses (gains) on intercompany transactions
+$4.33M Income Tax Impact of Adjustments: Amortization of acquired intangible assets
-$259K Income Tax Impact of Adjustments: Net (gain) loss on sale of businesses and assets
= Non-GAAP Adjusted Income Tax Provision $7.48M
Non-GAAP EBITDA non-GAAP $38.67M Three Months Ended July 31, 2026 —
Output growth 8% Q1 2027 —
Research Adjusted EBITDA non-GAAP $87M the first quarter of fiscal year 2027 —
Research Adjusted EBITDA margin non-GAAP 29.6% the first quarter of fiscal year 2027 —
Returns to Shareholders $33M the first quarter of fiscal year 2027 —
Share repurchases $15M the first quarter of fiscal year 2027 —
Spectral collection mass spectra 1.2M Q1 2027 —
Submissions growth 31% Q1 2027 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Publishing — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
WLY
John Wiley & Sons, Inc.
this stock
$2.44B +57.3% +4.5% 13.0 8.9%
NYT
New York Times Co
 $10.85B -3.1% -1.6% 28.0 7.1%
PSO
Pearson PLC
 $9.60B +13.8% — — 0.7%
SPGNY
Springer Nature AG & Co. KGaA/ADR
 $2.26B — — — 0.0%
TDAY
USA TODAY Co., Inc.
 $929.36M +22.9% +13.7% — 14.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
267
% held
82.6%
Net QoQ
-129.5K sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
311
View
Short & Settlement
Short Interest Rising
Shares short
4.5M
Days to cover
11.2d
Change
+356.9K sh
View
Short Volume
Short vol %
72%
As of
Sep 4, 2026
Short Total
View
Fails to Deliver
FTD shares
114
Value
$6.1K
As of
Aug 7, 2026
View
Off-Exchange
Off-exchange %
39.7%
Week of
Jul 27, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$1.7B
Net income (FY)
$221.6M
EPS diluted
$4.16
View
Buybacks
Authorized
$250.0M
Remaining
$192.4M
Spent Remaining
View
Filings
SEC Filings
Latest
10-Q
Filed
Sep 4, 2026
This year
12
View
Proposed Sales
Value
$653.5K
Shares
12.7K
Filed
Jul 2, 2026
View
Earnings & Events
Earnings Calls
Last call
Sep 3, 2026
View
Investor Relations
Latest news
Do School-Based Interventions Hel…
Published
Apr 7, 2021
View

Performance

5D 20D 120D MTD YTD
WLY -10.3% -7.9% +31.4% -8.0% +57.3%
SPY +0.1% -0.4% +15.1% +0.4% +12.9%
vs SPY -10.4% -7.5% +16.3% -8.4% +44.4%

Capital returns

Latest dividend
$0.3575 / share · ex Jul 7, 2026
Raised 0.7%
Paid (TTM)
$1.4225 / share · 4 payouts
Dividend yield (TTM, derived)
2.95%
Buyback program · as of Jul 31, 2026
Authorized
$250.00M
Spent (derived)
$57.60M
Remaining
$192.40M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 107140 CUSIP 968223206 13F (30d) 163 filings 163 filers Visit website Investor relations